Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
Clinical trial NCT03652259 · TERMINATED
Trial details
- NCT number
- NCT03652259
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-27
- Primary completion
- 2025-01-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.